Filter
575
Text search:
M.tuberculosis
Featured
Recommendations
64
New Publications
105
Language
Document type
No document type
394
Guidelines
81
Studies & Reports
45
Manuals
27
Strategic & Response Plan
12
Training Material
9
Situation Updates
4
Fact sheets
3
Countries / Regions
Western and Central Europe
43
Eastern Europe
25
India
23
Germany
14
Peru
10
Latin America and the Carribbean
10
Global
10
Nepal
9
Argentina
9
Colombia
9
Ethiopia
8
Tanzania
8
Paraguay
7
Russia
7
Indonesia
6
South Africa
6
Mozambique
6
Ukraine
6
El Salvador
6
Kenya
5
Cambodia
5
Bangladesh
5
Chile
5
Uganda
4
Zambia
4
Namibia
4
Myanmar / Burma
4
Nigeria
3
Ghana
3
Malawi
3
Asia
3
Tajikistan
3
Senegal
2
Philippines
2
Benin
2
Brazil
2
Ecuador
2
Bolivia
2
Uruguay
2
Sierra Leone
1
Liberia
1
Congo, Democratic Republic of
1
USA
1
Cameroon
1
Zimbabwe
1
South Sudan
1
Gambia
1
Eswatini/ Swaziland
1
Switzerland
1
Botswana
1
Lesotho
1
South–East Asia Region
1
Eastern Europe and Central Asia
1
Albania
1
Timor Leste/ East Timor
1
Estonia
1
Romania
1
Georgia
1
North America
1
Authors & Publishers
Publication Years
Category
Countries
172
Clinical Guidelines
69
Pharmacy & Technologies
12
Public Health
8
Capacity Building
6
Women & Child Health
6
Key Resources
3
Toolboxes
TB
382
HIV
37
NTDs
19
AMR
16
Polio
13
Ebola & Marburg
12
Refugee
10
Rapid Response
7
Caregiver
5
Malaria
3
Natural Hazards
2
Mental Health
2
COVID-19
2
Pharmacy
2
2.0 Rapid Response
2
Zika
1
A Guide for low income countries
La infección latente por tuberculosis (ILTB) es un estado de respuesta inmunitaria persistente a la estimulación por antígenos de Mycobacterium tuberculosis sin indicios de manifestaciones clínicas de tuberculosis activa
Informe sobre poblaciones clave.
Improving the management of childhood tuberculosis within national tuberculosis programmes: research priorities based on a literature review
WHO/HTM/TB/2007.381, 07.02
Prise en charge Intégrée des maladies de l’adolescent
et de l’adulte (PCIMAA)
Avril 2007
WHO/HTM/VIH/2007.01
WHO/HTM/TB/2007.380
TB remains one of the world’s deadliest infectious diseases, second only to COVID-19, and drug-resistant TB strains are still a major concern. In the fight against TB, urgent investment is critical, especially in the context of the ongoing pandemic.
The present Consolidated guidelines include a comprehensive set of WHO recommendations for the treatment and care of DR-TB, derived from these WHO guidelines documents. The consolidated guidelines include policy recommendations on treatment regimens for isoniazid-resistant TB (Hr-TB) and MDR/RR-TB,
...
Considerando los cambios estratégicos en el abordaje de la salud pública y de la atención primaria de la salud, la prevención y el control de la tuberculosis en Ecuador genera un cambio en la parte organizacional y en la prestación de servicios con enfoque en grupos vulnerables y/o con factores
...
Epidemiologisches Bulletin; 14. März 2016 Nr. 10/11 ;DOI 10.17886/EpiBull-2016-014
В основе настоящих руководящих принципов лежит структура организации мероприятий в соответствии с тремя задачами:
• создание и укрепление механизмов комплексно
...
Servicios de Salud locales, distritales, regionales y Unidades de salud de la Familia
In case of resistance to rifampicin, fluoroquinolones become the preferred category of second-line drugs. Unfortunately, quinolone-resistant strains of Mycobacterium leprae have also been reported in several countries, probably due to the extensive use of quinolones for treating several types of inf
...
A survey was conducted in countries in all six WHO regions and focused on the building blocks that are considered prerequisites to combat antimicrobial resistance: a comprehensive national plan, laboratory capacity to undertake surveillance for resistant microorganisms, access to safe, effective ant
...